Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03001401Phase 4Unknown

Comparison of Next Generation Laser Techniques of Myopia Correction: iDesign vs. SMILE

Role: lead

NCT01746823Unknown

Identification and Validation of Functional Biomarkers for Keratoconus

Role: lead

NCT00403026Not ApplicableUnknown

Intravitreal Bevacizumab for Retinal Disorders

Role: lead

All 3 trials loaded